In view of recent knowledge on proteins regulating the cell cycle, we re-evaluated proliferative features of 98 diffusely growing non-Hodgkin's lymphomas. The combined use of 5 proliferation-associated variables (mitotic indices and percentages of Ki-673, p3(4cdc)2+, cyclin A+ and cyclin B+ cells) and their entry into a multivariate cluster analysis separated, without overlaps, the entire cohort into 3 groups (clusters) with (1) low, (2) intermediate and (3) high proliferative activity. Conversely, bivariate plots exposed considerable cluster overlaps. Multivariate stepwise discriminant analysis of all cases revealed a decreasing order of discriminant power for% Ki-67+ cells > % p34(cdc)2+ cells > mitotic index > % cyclin A+ cells > % cyclin B+ cells. The combined use of 2 variables only, mitotic index and % p34(cdc)2+ cells, allowed a clear-cut separation of clusters 2 and 3. In bivariate plots, correlations were best between % Ki- 67+ cells and % cyclin A+ cells and between mitotic indices and % cyclin B+ cells. Except for chronic lymphocytic leukemias, immunocytomas and marginal zone lymphomas (all in cluster 1), individual lymphoma entities were distributed among at least 2 clusters. There was, however, a marked preponderance of mantle cell lymphomas and diffuse follicular center lymphomas in cluster 1 and of diffuse large B-cell lymphomas and peripheral T-cell lymphomas in cluster 2. Anaplastic large-cell lymphomas predominated in cluster 3 and responded best to therapy
Leoncini, L., Cossu, A., Megha, T., Bellan, C., Lazzi, S., Luzi, P., et al. (1999). Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis. INTERNATIONAL JOURNAL OF CANCER, 83(2), 203-209 [10.1002/(SICI)1097-0215(19991008)83:2<203::AID-IJC10>3.3.CO;2-S].
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis
Leoncini, Lorenzo;Bellan, Cristiana;Lazzi, Stefano;Luzi, Pietro;Tosi, Piero;Barbini, Paolo;Cevenini, Gabriele;Giordano, Antonio;
1999-01-01
Abstract
In view of recent knowledge on proteins regulating the cell cycle, we re-evaluated proliferative features of 98 diffusely growing non-Hodgkin's lymphomas. The combined use of 5 proliferation-associated variables (mitotic indices and percentages of Ki-673, p3(4cdc)2+, cyclin A+ and cyclin B+ cells) and their entry into a multivariate cluster analysis separated, without overlaps, the entire cohort into 3 groups (clusters) with (1) low, (2) intermediate and (3) high proliferative activity. Conversely, bivariate plots exposed considerable cluster overlaps. Multivariate stepwise discriminant analysis of all cases revealed a decreasing order of discriminant power for% Ki-67+ cells > % p34(cdc)2+ cells > mitotic index > % cyclin A+ cells > % cyclin B+ cells. The combined use of 2 variables only, mitotic index and % p34(cdc)2+ cells, allowed a clear-cut separation of clusters 2 and 3. In bivariate plots, correlations were best between % Ki- 67+ cells and % cyclin A+ cells and between mitotic indices and % cyclin B+ cells. Except for chronic lymphocytic leukemias, immunocytomas and marginal zone lymphomas (all in cluster 1), individual lymphoma entities were distributed among at least 2 clusters. There was, however, a marked preponderance of mantle cell lymphomas and diffuse follicular center lymphomas in cluster 1 and of diffuse large B-cell lymphomas and peripheral T-cell lymphomas in cluster 2. Anaplastic large-cell lymphomas predominated in cluster 3 and responded best to therapyFile | Dimensione | Formato | |
---|---|---|---|
leoncini l et al Int J Cancer 1999.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
172.4 kB
Formato
Adobe PDF
|
172.4 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/44779
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo